• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地高辛与索他洛尔联合用于胎儿室上性心动过速的产前管理:病例报告及文献综述

Prenatal management with digoxin and sotalol combination for fetal supraventricular tachycardia: case report and review of literature.

作者信息

Suri Vanita, Keepanaseril Anish, Aggarwal Neelam, Vijayvergiya Rajesh

机构信息

Department of Obstetrics and Gynecology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

Indian J Med Sci. 2009 Sep;63(9):411-4.

PMID:19805921
Abstract

Sustained fetal supraventricular tachycardia (SVT) with a heart rate of approximately 210 bpm may lead to increased atrial and venous pressures and congestive heart failure. There is no clear consensus regarding the best drug-treatment regimens for fetal SVT. However, considerable nonrandomized experience in the transmaternal treatment of fetal SVT is available with a number of antiarrhythmic agents. We report a case of fetal supraventricular tachyarrhythmia with hydrops detected at 32 weeks that was managed with combination of oral digoxin and sotalol and review management guidelines available in the literature.

摘要

持续的胎儿室上性心动过速(SVT),心率约为210次/分钟,可能会导致心房和静脉压力升高以及充血性心力衰竭。关于胎儿SVT的最佳药物治疗方案,目前尚无明确的共识。然而,有许多抗心律失常药物可用于经母体治疗胎儿SVT,且已有相当多的非随机经验。我们报告一例在32周时检测出患有水肿的胎儿室上性心律失常病例,该病例采用口服地高辛和索他洛尔联合治疗,并回顾了文献中可用的管理指南。

相似文献

1
Prenatal management with digoxin and sotalol combination for fetal supraventricular tachycardia: case report and review of literature.地高辛与索他洛尔联合用于胎儿室上性心动过速的产前管理:病例报告及文献综述
Indian J Med Sci. 2009 Sep;63(9):411-4.
2
Sotalol as an effective adjunct therapy in the management of supraventricular tachycardia induced fetal hydrops fetalis.索他洛尔作为治疗胎儿水肿胎儿室上性心动过速的有效辅助治疗药物。
J Neonatal Perinatal Med. 2020;13(2):267-273. doi: 10.3233/NPM-190268.
3
Can digoxin and sotalol therapy for fetal supraventricular tachycardia and hydrops be successful? A case report.地高辛和索他洛尔治疗胎儿室上性心动过速和水肿能否成功?一例病例报告。
J Reprod Med. 2008 May;53(5):357-9.
4
Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias.索他洛尔作为胎儿室上性心动过速一线治疗的疗效。
Am J Cardiol. 2012 Jun 1;109(11):1614-8. doi: 10.1016/j.amjcard.2012.01.388. Epub 2012 Mar 22.
5
Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.索他洛尔作为胎儿心动过速的一线治疗药物及新生儿随访。
Ultrasound Obstet Gynecol. 2013 Sep;42(3):285-93. doi: 10.1002/uog.12390.
6
Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.比较胎儿室上性心动过速的经胎盘治疗与地高辛、氟卡尼和索他洛尔:一项非随机多中心研究的结果。
Circulation. 2011 Oct 18;124(16):1747-54. doi: 10.1161/CIRCULATIONAHA.111.026120. Epub 2011 Sep 19.
7
Resolution of Fetal Hydrops Dependent on Sustained Fetal Supraventricular Tachycardia after Digoxin Therapy.地高辛治疗后依赖胎儿房性心动过速持续存在而缓解的胎儿水肿。
Medicina (Kaunas). 2020 May 7;56(5):223. doi: 10.3390/medicina56050223.
8
Transplacental Therapeutic Drug Monitoring in Pregnant Women with Fetal Tachyarrhythmia Using HPLC-MS/MS.采用 HPLC-MS/MS 技术对胎儿心动过速孕妇进行胎盘内治疗药物监测。
Int J Mol Sci. 2023 Jan 17;24(3):1848. doi: 10.3390/ijms24031848.
9
Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.胎儿室上性心动过速的产前治疗:多中心试验。
J Am Coll Cardiol. 2019 Aug 20;74(7):874-885. doi: 10.1016/j.jacc.2019.06.024.
10
[Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].[室上性心动过速胎儿的产前管理结果。66例系列研究]
J Gynecol Obstet Biol Reprod (Paris). 2003 Jun;32(4):338-44.

引用本文的文献

1
Complete resolution of arrhythmia-induced hydrops fetalis in utero.胎儿心律失常性水肿宫内完全消退。
BMJ Case Rep. 2020 Oct 10;13(10):e235827. doi: 10.1136/bcr-2020-235827.
2
Maternal monitoring and safety considerations during antiarrhythmic treatment for fetal supraventricular tachycardia.胎儿室上性心动过速抗心律失常治疗期间的母体监测及安全性考量
Obstet Med. 2019 Jun;12(2):66-75. doi: 10.1177/1753495X18808118. Epub 2018 Nov 15.
3
Fetal Arrhythmias: Genetic Background and Clinical Implications.胎儿心律失常:遗传背景与临床意义
Pediatr Cardiol. 2019 Feb;40(2):247-256. doi: 10.1007/s00246-018-2008-3. Epub 2018 Nov 26.
4
Successful medical treatment of fetal supraventricular tachycardia that cause hydrops fetalis.成功治疗导致胎儿水肿的胎儿室上性心动过速。
Turk J Obstet Gynecol. 2014 Sep;11(3):193-195. doi: 10.4274/tjod.56578. Epub 2014 Sep 15.
5
Therapeutic effect of prenatal alkalization and PTC124 in Na(+)/HCO3(-) cotransporter 1 p.W516* knock-in mice.PTC124 在 Na(+)/HCO3(-) 共转运蛋白 1 p.W516* 敲入小鼠中产前碱化的治疗效果。
Gene Ther. 2015 May;22(5):374-81. doi: 10.1038/gt.2015.7. Epub 2015 Feb 26.